1. Simulation and Matching-Based Approaches for Indirect Comparison of Treatments

   • K. Jack Ishak
   • Irina Proskorovsky
   • Agnes Benedict

   Leading Article 21 March 2015 Pages: 537 - 549

   

2. A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry

   • Hedwig M. Blommestein
   • Margreet G. Franken
   • Carin A. Uyl-de Groot

   Practical Application Open access 03 February 2015 Pages: 551 - 560

3. Pharmacological Management of Chronic Lower Back Pain: A Review of Cost Effectiveness

   • Marion Haas
   • Richard De Abreu Lourenco

   Review Article 22 January 2015 Pages: 561 - 569

   

4. Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?

   • James Buchanan
   • Sarah Wordsworth

   Review Article 14 February 2015 Pages: 571 - 579

   

5. Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes

   • Jinsong Geng
   • Hao Yu
   • Yingyao Chen

   Systematic Review 04 March 2015 Pages: 581 - 597

   

6. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program

   • Francisco Jódar-Sánchez
   • Amaia Malet-Larrea
   • Shalom I. Benrimoj

   Original Research Article 15 March 2015 Pages: 599 - 610

   

7. Erratum to: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex^®) for Spasticity in Multiple Sclerosis

   • Lanting Lu
   • Hilary Pearce
   • Ken Stein

   Erratum 24 April 2015 Pages: 611 - 611